These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 4266330

  • 21. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y, Kaneko M, Yashima Y, Kumashiro H.
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract] [Full Text] [Related]

  • 22. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB, Strauss D.
    J Insur Med; 1997 Jun; 29(3):172-84. PubMed ID: 10176367
    [Abstract] [Full Text] [Related]

  • 23. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R, Ugazio AG, Nespoli L, Alberini C, Montagna D, Porta F, Bonetti F, Burgio GR.
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [Abstract] [Full Text] [Related]

  • 24. [Studies on sex-dimorphism of peripheral blood granulocytes in the Langdon-Down syndrome].
    Dobrzańska A, Gajewska E.
    Pol Tyg Lek; 1967 Dec 04; 22(49):1879-83. PubMed ID: 4233241
    [No Abstract] [Full Text] [Related]

  • 25. [Radiosensitivity of chromosomes in lymphocytes from Down's syndrome patients].
    Akif'ev AP, Mutovin GR, Filiushkin IV, Khandogina EK.
    Biull Eksp Biol Med; 1983 Dec 04; 96(12):69-71. PubMed ID: 6229291
    [Abstract] [Full Text] [Related]

  • 26. Familial Down's syndrome.
    Maximilian C, Pop T, Duca D, Simionescu L, Danielescu M, Ioan D.
    Endocrinologie; 1981 Dec 04; 19(1):65-8. PubMed ID: 6457382
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A survey of 972 cytogenetically examined cases of Down's syndrome.
    Gardner RJ, Veale AM, Parslow MI, Becroft DM, Shaw RL, Fitzgerald PH, Hutchings HE, McCreanor HR, Wong J, Eiby JR, Howarth DA, Whyte SE.
    N Z Med J; 1973 Nov 14; 78(502):403-9. PubMed ID: 4272131
    [No Abstract] [Full Text] [Related]

  • 30. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A, Grunewald C, Saltvedt S, Valentin L, Almström H.
    Acta Obstet Gynecol Scand; 2006 Nov 14; 85(5):534-8. PubMed ID: 16752230
    [Abstract] [Full Text] [Related]

  • 31. Middle ear effusion in Down's syndrome patients.
    Samuelson ME, Nguyen VT.
    Nebr Med J; 1980 Apr 14; 65(4):83-4. PubMed ID: 6445043
    [No Abstract] [Full Text] [Related]

  • 32. Ocular health status of subjects with Down's syndrome in Benin City, Nigeria.
    Ebeigbe JA, Akpalaba R.
    Afr J Med Med Sci; 2006 Sep 14; 35(3):365-8. PubMed ID: 17312746
    [Abstract] [Full Text] [Related]

  • 33. ["E" and "EAC" rosette tests of peripheral blood in children with Down's syndrome].
    Kobielowa Z, Pietrzyk J, Mytar B, Mitkowska Z.
    Pediatr Pol; 1980 May 14; 55(5):609-15. PubMed ID: 6447268
    [No Abstract] [Full Text] [Related]

  • 34. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP.
    Diabetes; 2006 Nov 14; 55(11):3185-8. PubMed ID: 17065360
    [Abstract] [Full Text] [Related]

  • 35. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M, Porcaro L, Ruscica M, De Simone E, Bertelli AA, Corsi MM.
    Int J Clin Pharmacol Res; 2001 Nov 14; 21(2):79-84. PubMed ID: 11824651
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Studies of granulopoiesis and granulocyte kinetics in Down's syndrome.
    Pearson HA.
    Pediatrics; 1967 Jul 14; 40(1):92-5. PubMed ID: 4226372
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R, Nurmi T, Ilonen J, Surcel HM.
    Clin Exp Immunol; 1984 Feb 14; 55(2):257-63. PubMed ID: 6230181
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.